Elevance Health Inc. logo
Elevance Health Inc. (ELV)
Compare

Elevance Health Inc. (ELV) Net Income CAGR:-11.40%(TTM)

Stocks/ELV Stock/Performance/net income cagr
Compare

The net income cagr for Elevance Health Inc. (ELV) is -11.40% over the latest trailing 12-month period. Net income CAGR uses precomputed financial statement history.

The net income cagr for Elevance Health Inc. (ELV) stock is -11.40% over the past 12 months. The 3 year average growth rate is -4.89% and the 5 year cagr is 2.15%. Net income CAGR shows how Elevance Health Inc.'s bottom-line profitability has grown. This reflects the company's ability to convert revenue into profits after all expenses.

ELV Net Income CAGR Chart

Elevance Health Inc. (ELV)

ELV Net Income CAGR History

YearStart Net IncomeEnd Net IncomeChange% ChangeCAGR
2025$5.98B$5.66B$-318.00M-5.32%-5.32%
2024$5.99B$5.98B$-7.00M-0.12%-0.12%
2023$5.89B$5.99B+$93.00M+1.58%+1.58%
2022$6.10B$5.89B$-210.00M-3.44%-3.44%
2021$4.57B$6.10B+$1.53B+33.51%+33.51%
2020$4.81B$4.57B$-235.00M-4.89%-4.89%
2019$3.75B$4.81B+$1.06B+28.19%+28.19%
2018$3.84B$3.75B$-92.80M-2.41%-2.41%
2017$2.47B$3.84B+$1.37B+55.59%+55.59%
2016$2.56B$2.47B$-90.20M-3.52%-3.52%
2015$2.57B$2.56B$-9.70M-0.38%-0.38%
2014$2.65B$2.57B$-84.50M-3.18%-3.18%
2013$2.66B$2.65B$-1.30M-0.05%-0.05%
2012$2.65B$2.66B+$8.80M+0.33%+0.33%
2011$2.89B$2.65B$-240.40M-8.33%-8.33%
2010$4.75B$2.89B$-1.86B-39.17%-39.17%
2009$2.49B$4.75B+$2.26B+90.54%+90.54%
2008$3.35B$2.49B$-854.70M-25.55%-25.55%
2007$3.09B$3.35B+$250.50M+8.09%+8.09%
2006$2.46B$3.09B+$631.10M+25.61%+25.61%
2005$960.10M$2.46B+$1.50B+156.62%+156.62%
2004$774.30M$960.10M+$185.80M+24.00%+24.00%
2003$549.10M$774.30M+$225.20M+41.01%+41.01%
2002$342.20M$549.10M+$206.90M+60.46%+60.46%
2001$226.00M$342.20M+$116.20M+51.42%+51.42%
2000$44.90M$226.00M+$181.10M+403.34%+403.34%
1999$172.40M$44.90M$-127.50M-73.96%-73.96%

Quarterly Net Income — QoQ & YoY

QuarterValueQoQYoY
Q1 2026$1.76B+222.5%-19.2%
Q4 2025$547.00M-54.0%+30.9%
Q3 2025$1.19B-31.8%+17.0%
Q2 2025$1.74B-20.2%-24.2%
Q1 2025$2.18B+422.2%-2.8%
Q4 2024$418.00M-58.9%-51.2%
Q3 2024$1.02B-55.8%-21.2%
Q2 2024$2.30B+2.4%+24.1%
Q1 2024$2.25B+162.4%+12.9%
Q4 2023$856.00M-33.6%-1.0%
Q3 2023$1.29B-30.4%-19.6%
Q2 2023$1.85B-6.8%+13.2%
Q1 2023$1.99B+129.9%+11.2%
Q4 2022$865.00M-46.0%-23.9%
Q3 2022$1.60B-2.1%+6.2%
Q2 2022$1.64B-8.5%-8.7%

QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.

About Elevance Health Inc.

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

Indianapolis, IN
104,200 employees
Healthcare / Medical - Healthcare Plans
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Gail Koziara Boudreaux